Immune Checkpoint Inhibitors for Head and Neck Squamous Cell Carcinoma

被引：0
|
作者：
Chang, Hui-Chin [1 ,2 ]
Gau, Shuo-Yan [3 ]
机构：
[1] Chung Shan Med Univ, Chung Shan Med Univ Hosp, Evidence Based Med Ctr, Taichung, Taiwan
[2] Chung Shan Med Univ, Sch Med, Taichung, Taiwan
[3] Natl Taiwan Univ, Dept & Grad Inst Business Adm, 1 Sec 4 Roosevelt Rd, Taipei 106319, Taiwan
来源：
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY | 2025年 / 151卷 / 02期
关键词：
D O I：
10.1001/jamaoto.2024.3966
中图分类号：
R76 [耳鼻咽喉科学];
学科分类号：
100213 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Immune Checkpoint Inhibitors for Head and Neck Squamous Cell Carcinoma-Reply
    Mastrolonardo, Eric V.
    Llerena, Pablo
    Curry, Joseph M.
    JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2025, 151 (02)
  • [2] Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
    Oliva, M.
    Spreafico, A.
    Taberna, M.
    Alemany, L.
    Coburn, B.
    Mesia, R.
    Siu, L. L.
    ANNALS OF ONCOLOGY, 2019, 30 (01) : 57 - 67
  • [3] Current and Future Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
    Park, Jong Chul
    Krishnakumar, Hari N.
    Saladi, Srinivas Vinod
    CURRENT ONCOLOGY, 2022, 29 (06) : 4185 - 4198
  • [4] Immune checkpoint inhibitors for head and neck squamous cell carcinoma: Current landscape and future directions
    Kao, Hsiang-Fong
    Lou, Pei-Jen
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 : 4 - 18
  • [5] Genomic correlates of response to immune checkpoint inhibitors in advanced head and neck squamous cell carcinoma
    Patel, Nisarg A.
    Vokes, Natalie, I
    Elmarakeby, Haitham
    Hanna, Glenn J.
    Van Allen, Eliezer M.
    CANCER RESEARCH, 2020, 80 (16)
  • [6] Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma
    Zi Mei
    Junwen Huang
    Bin Qiao
    Alfred King-yin Lam
    International Journal of Oral Science, 2020, 12
  • [7] Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma
    Zi Mei
    Junwen Huang
    Bin Qiao
    Alfred King-yin Lam
    International Journal of Oral Science, 2020, (02) : 114 - 122
  • [8] Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma
    Mei, Zi
    Huang, Junwen
    Qiao, Bin
    Lam, Alfred King-yin
    INTERNATIONAL JOURNAL OF ORAL SCIENCE, 2020, 12 (01)
  • [9] Hypothyroidism in Head and Neck Squamous Cell Carcinoma Patients Receiving Radiotherapy With or Without Immune Checkpoint Inhibitors
    Leddon, Jennifer L.
    Chirra, Martina
    Frankart, Andrew J.
    Agrawal, Arushi
    Roof, Logan
    Trotier, Danny
    Shaikh, Hira
    Stone, Timothy
    Jandarov, Roman
    Takiar, Vinita
    Wise-Draper, Trisha M.
    LARYNGOSCOPE, 2021, 131 (07): : E2413 - E2419
  • [10] Clinical implications of hyperprogression with immune checkpoint inhibitors in patients with head and neck squamous cell carcinoma (HNSCC).
    Economopoulou, Panagiota
    Spathas, Nikolaos Spiridon
    Papaxoinis, George
    Anastasiou, Maria
    Gkotzamanidou, Maria
    Kotsantis, Ioannis
    Gavrielatou, Niki
    Oikonomopoulos, Nikolaos
    Kirodimos, Euthymios
    Vagia, Elena Mihal
    Kavourakis, George
    Psyrri, Amanda
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345